FindTrial
Sign In

Detection of circulating tumor cells (CTC) with novel viral marker (OBP-401) for patients with prostate cancer

Detection of circulating tumor cells (CTC) with novel viral marker (OBP-401) for patients with prostate cancer - Detection of CTC with OBP-401 for prostate cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000010410
Enrollment
50
Registered
2013-04-04
Start date
2013-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

None listed

Sponsors

Department of Urology, Kobe university graduate school of medicine
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1) Prostate cancer patient 2) Patient who needs routine blood test 3) Needs informed consent

Exclusion criteria

Exclusion criteria: 1) Infection 2) Patients whose physician deems as inadequate 3) refusal

Design outcomes

Primary

MeasureTime frame
Enumeration of circulating tumor cells and its correlation to the other clinical outcomes Phenotypic analysis of the circulating tumor cells—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026